9OCG image
Deposition Date 2025-04-24
Release Date 2025-09-10
Last Version Date 2026-03-18
Entry Detail
PDB ID:
9OCG
Title:
Transporter associated with antigen processing (TAP) bound to the viral protein BNLF2a in the inward-facing state
Biological Source:
Source Organism(s):
Expression System(s):
Method Details:
Experimental Method:
Resolution:
3.80 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Antigen peptide transporter 1
Gene (Uniprot):TAP1
Chain IDs:C (auth: A)
Chain Length:887
Number of Molecules:1
Biological Source:Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Antigen peptide transporter 2
Gene (Uniprot):TAP2
Chain IDs:A (auth: B)
Chain Length:686
Number of Molecules:1
Biological Source:Homo sapiens
Protein Blast
Polymer Type:polypeptide(L)
Molecule:TAP transport inhibitor BNLF2
Gene (Uniprot):BNLF2a
Chain IDs:B (auth: C)
Chain Length:95
Number of Molecules:1
Biological Source:human gammaherpesvirus 4
Ligand Molecules
Primary Citation
Structurally diverse viral inhibitors converge on a shared mechanism to stall the antigen transporter TAP.
Proc. Natl. Acad. Sci. U.S.A. 122 e2516676122 e2516676122 (2025)
PMID: 40956880 DOI: 10.1073/pnas.2516676122

Abstact

In the host-pathogen arms race, herpesviruses and poxviruses encode proteins that sabotage the transporter associated with antigen processing (TAP), thereby suppressing MHC-I antigen presentation and enabling lifelong infection. Of the five known viral TAP inhibitors, only the herpes simplex virus (HSV) protein ICP47 has been structurally resolved. We now report cryoelectron microscopy structures of TAP in complex with the remaining four: BNLF2a (Epstein-Barr virus), hUS6 (human cytomegalovirus), bUL49.5 (bovine herpesvirus 1), and CPXV012 (cowpox virus), assembling a structural atlas of viral TAP evasion. Despite employing divergent sequences, folds, and conformational targets, these viral inhibitors converge on a common strategy: they stall TAP from the alternating access cycle, precluding peptide entry into the ER and shielding infected cells from cytotoxic T cell surveillance. These findings reveal striking functional convergence and provide a structural framework for rational antiviral design.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback